University of California Los Angeles /ID# 282444 — Los Angeles, California

University of California Los Angeles /ID# 282444 is a clinical research site located in Los Angeles, California, United States 90095-3075.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of California Los Angeles /ID# 282444 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California Los Angeles /ID# 282444?

University of California Los Angeles /ID# 282444 has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California Los Angeles /ID# 282444 conducted?

University of California Los Angeles /ID# 282444 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Multiple Myeloma.

Is University of California Los Angeles /ID# 282444 accredited by Crixeo Clinical Trials?

University of California Los Angeles /ID# 282444 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California Los Angeles /ID# 282444?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.